Foundation Medicine, Inc.

Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical practice. The company connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and creating a personalized clinical action plan, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.

Developer of precision medicine in oncology designed to provide big data analysis in cancer. The company develops a cell-free liquid biopsy technology, enabling healthcare professionals to use minimally-invasive molecular diagnosis for treatment selection, therapy monitoring, and detection of cancer earlier.

Developer of a biotechnology platform designed to combine genomic and phenotypic information to accelerate the understanding of human health. The company's platform addresses the age-related decline in endogenous stem cell function and concentrates on cancer, diabetes and obesity, heart and liver diseases and dementia by combining deoxyribonucleic acid sequencing and expert analysis with machine learning, enabling people to shape their health and shift the practice of medicine from reactive to proactive technologies.